E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/12/2005 in the Prospect News Biotech Daily.

Medisys maintained by Jennings at sell

Medisys Health Group Inc. was maintained by Jennings Capital Inc. with a sell recommendation, following the recent completion of two Toronto-based medical imaging companies. The firm is keeping a price target on the stock of C$6.25. On the Toronto exchange, Medisys shares Tuesday were unchanged at C$4.58, on volume of 5,900 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.